Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CIROZ encodes a protein expressed specifically in the ciliated left-right organizer of vertebrate embryos, where it helps break bilateral symmetry by contributing to left-right axis specification. The protein contains a signal peptide and three zona pellucida N (ZP-N) domains, indicating it is likely secreted or extracellular and homologous to ZP glycoproteins such as ZP2. Loss-of-function mutations in CIROZ can cause heterotaxy syndrome with congenital heart defects in humans and left-right patterning defects in mice. However, this function is not universally conserved across vertebrates, as knockout studies in zebrafish and Xenopus do not show laterality defects, and the gene is pseudo-genized in some mammalian lineages (Laurasiatheria). CIROZ is not considered a drug target and is not implicated directly in pharmacology or therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliated left-right organizer protein containing ZP-N domains (CIROZ).